reglab/statecodes huggingface dataset:
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 10 - SUBSTANCE ABUSE COUNSELING AND SUPPORTIVE SERVICES › Section 10:161B-10.4 - Co-occurring services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Programs
				providing treatment to clients diagnosed with co-occurring disorders shall have
				clearly written policies and procedures governing the integrated treatment
				(assessment, diagnosing and service provision) of individuals diagnosed with
				co-occurring disorders.
1. Policies and
				procedures shall include the qualifications of clinical and medical staff
				responsible for assessing and diagnosing clients with co-occurring disorders
				and providing treatment and medical services to clients diagnosed with
				co-occurring disorders.
2. The
				facility shall ensure that appropriate clinical supervision is provided to
				staff providing treatment and services to clients diagnosed with co-occurring
				disorders.
3. The facility shall
				develop policies and procedures for case consultation, coordination and, where
				appropriate, referral to mental heath treatment services in order to ensure
				coordinated service provision.
4.
				The director of substance abuse counseling services and director of nursing
				services shall ensure that the client treatment plan addresses both the
				client's substance abuse and mental health disorders.
5. Only counselors possessing the appropriate
				qualifications may provide assessment and diagnosis of co-occurring addiction
				and mental illness. All services delivered to co-occurring clients must be
				supervised by staff whose credentials are equivalent to the director of
				substance abuse counseling, as noted in
				10:161B-1.8(a).
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.2 - Staffing

Current through Register Vol. 56, No. 14, July 15, 2024
(a) All opioid treatment programs shall have
				a medical director who shall be ASAM certified, or certified by its successor
				board, by June 1, 2012 in accordance with
10:161B-1.4
. The medical
				director or other designated program physician shall be available on site or by
				telephone during all operating hours of the opioid treatment program. A
				physician, licensed to practice in the State of New Jersey, who worked a
				minimum of five years at least 20 hours per week and has completed the
				ASAM/AATOD clinician's training course, may be considered for a waiver of the
				above provision.
(b) All opioid
				treatment programs shall employ a full-time director of substance abuse
				counseling services who meets the qualifications of
				10:161B-1.8.
(c) All opioid treatment programs shall
				employ a director of nursing services who meets the requirements of
				10:161B-1.5.
(d) All opioid treatment programs shall
				employ counseling staff who meet the requirements of
				10:161B-1.9(a)1.
				An opioid treatment program shall employ an adequate number of counseling staff
				to provide services in accordance with
				10:161B-10.1(b),
				and as necessary to address the individualized needs of each client, including
				documented responses to changes in client status or failure to achieve
				treatment goals and outcomes.
(e)
				Only physicians, registered professional nurses, or licensed practical nurses
				(working under the on-site supervision of a registered professional nurse),
				pharmacists or other persons authorized under New Jersey statutes or rules may
				dispense or administer medications in a facility providing opioid treatment
				program services.
(f) A registered
				professional nurse shall be present onsite during every hour in which
				medication is administered. A registered professional nurse or licensed
				practical nurse shall be assigned to the medicating area to observe client
				status prior to medicating.
1. Clients
				observed or suspected of being under the influence of alcohol or other
				psychoactive drugs shall be assessed by the registered professional nurse or
				physician to determine the appropriateness of medicating.
2. If the registered professional nurse is
				administering medication on the medication line, an additional registered
				professional nurse is not required.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.3 - Multidisciplinary team

Current through Register Vol. 56, No. 14, July 15, 2024
Clinical decisions regarding phase changes, take home
				  privileges and other treatment issues shall be based on a multidisciplinary
				  team review of each client. Documentation of the multidisciplinary team review
				  with the recommended course of action shall be in the client's chart and
				  include team members' signatures. The multidisciplinary team shall, at a
				  minimum, consist of the medical director or physician, director of substance
				  abuse counseling services, director of nursing services or program nurse, and
				  the client's primary substance abuse counselor.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.4 - Policies and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Opioid
				treatment programs shall develop and implement written policies and procedures
				to include the following:
1. Medication
				management, including:
i. The
				responsibilities of the medical director, other physicians, and other health
				care professionals;
ii. The role of
				physicians regarding admission, dosage, and discharge;
iii. Establishing the initial and maintenance
				dose;
iv. Unsupervised
				dosing;
v. Emergency administration
				of medications;
vi. Diversion
				control plan;
vii. Medicating
				traveling clients; and
viii. Safe
				storage practices for unsupervised medications to include the use of
				child-proof or child-resistant containers;
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.5 - Minimum standards for admission to an opioid treatment program

Current through Register Vol. 56, No. 14, July 15, 2024
(a)
				Opioid treatment programs shall give preference for admission to pregnant
				women, intravenous (IV) drug users, and individuals who are
				HIV-positive.
(b) All persons
				admitted to an opioid treatment program shall meet the admission criteria
				outlined in the Federal standards set by accrediting agencies contained in 42
				CFR Part 8.12. Program criteria for admission shall be based on the definition
				of opioid dependence in DSM-5. The client record shall document a DSM-5
				diagnosis by a qualified clinician and/or a determination that opioid
				maintenance therapy on an outpatient basis is appropriate according to ASAM
				Criteria.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.6 - Admissions and assessment

Current through Register Vol. 56, No. 14, July 15, 2024
(a) In addition to
				meeting the eligibility criteria for admission, a client admitted to an opioid
				treatment program shall receive a biopsychosocial assessment in accordance with
				10:161B-9.1(a).
(b) Drug screening shall be analyzed, at a
				minimum, for opioids, methadone, cocaine, amphetamines, and benzodiazepines,
				and, as appropriate, for drugs of choice as evidenced in evaluation and/or
				intake assessment. Screening for alcohol, marijuana and other drugs shall be
				conducted based on individual and/or community drug use patterns in accordance
				with program policy established by the multidisciplinary team. Positive drug
				screens for other substances shall be documented in the client's case record
				and an appropriate clinical intervention will occur.
(c) An opioid treatment program shall conduct
				a complete physical examination, a medical history including drug use and
				current medications, treatment history and personal history before dispensing
				or administering medication. A program physician or other licensed independent
				practitioner authorized under New Jersey statutes shall conduct a complete
				physical examination at admission and shall include testing for the following:
1. Serological test for syphilis and testing
				for other sexually transmitted diseases as medically indicated;
2. Mantoux tuberculin skin test at admission
				and annually thereafter and chest x-ray if medically indicated. Testing shall
				be provided in accordance with the Tuberculosis Surveillance Procedures for
				Substance Abuse Treatment Facilities (SATFs), incorporated herein as chapter
				Appendix A;
3. Urine or other
				approved screening to identify drug use;
4. Routine and microscopic
				urinalysis;
5. Complete Blood Count
				(CBC);
6. SMA 12 or comparable
				screening;
7. Pregnancy test for
				women;
8. Screening for Hepatitis C
				and Hepatitis B surface antigen and antibody is highly recommended but not
				required;
9. All clients shall
				receive HIV pre-test counseling, and shall be offered HIV testing onsite or at
				a DOH/HIV, STD, and TB Services approved rapid HIV testing clinic, with
				referral documented in the client file; however, a client has the right to
				refuse HIV testing. Documentation of refusal must be contained in the client
				file; and
10. Mental health status
				evaluation to include previous psychiatric admissions, and a history of
				suicidal ideation, outpatient psychiatric treatment, psychotropic medications
				and, when clinically indicated, an assessment by a psychiatrist or other
				licensed clinician of clients diagnosed and identified as having a co-occurring
				mental health disorder.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.7 - Medical assessments

Current through Register Vol. 56, No. 14, July 15, 2024
(a) In all years
				after the year of admission to an opioid treatment program, a client shall
				receive either an annual physical examination by a program physician or other
				licensed independent practitioner under New Jersey statutes, or an annual
				nursing assessment by a registered professional nurse according to a protocol
				established by the facility's medical director.
(b) Clients shall be referred to or provided
				additional medical services, as indicated by the physical examination or
				nursing assessment. Documentation of physical examinations or nursing
				assessments, as well as referrals and follow up, shall be included in the
				client record.
(c) When medically
				indicated, the opioid treatment program shall attempt to obtain written
				authorization from the client authorizing program medical staff to coordinate
				medical care with the client's primary care provider, if different than the
				opioid treatment program. Client refusal shall also be documented in the
				client's clinical record.
(d) All
				clients must have access to a program physician or a registered nurse for an
				appointment or telephone consultation within 72 hours or three business days of
				making a medically appropriate request. Documentation of the client's request
				shall be placed in the client's file.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.8 - Counseling services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) As part of a
				multidisciplinary team approach, an opioid treatment program shall provide
				counseling services in accordance with
				10:161B-10.1.
(b) All opioid treatment programs shall
				provide counseling services, at a minimum, in accordance with the Phase
				schedule set forth below. Clients shall be considered for movement from one
				phase to another when the multidisciplinary team review has determined that the
				client has progressed in treatment and meets the following criteria:
1. For Phase I: Upon admission.
i. The client shall receive at least one
				counseling session per week with at least one individual counseling session per
				month, a total of four counseling sessions per month;
ii. A client shall be considered for Phase II
				based upon the review, recommendation and documentation of the
				multidisciplinary team after three consecutive months of negative drug
				screenings and compliance with other criteria established by the program;
				and
iii. Minimum duration of Phase
				I shall be three months if all drug screening results are negative;
				re-assessment shall take place at this time.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.9 - Drug screening

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Random drug
				screening shall be conducted on varied days and weeks of the month to detect,
				at a minimum, the presence of opioids, methadone, cocaine, amphetamines, and
				benzodiazapenes. Screening for alcohol, marijuana and other drugs shall be
				conducted based on individual and/or community drug use patterns in accordance
				with program policy established by the multidisciplinary team.
(b) Random drug screening to identify
				continued drug abuse shall be conducted every two weeks until the client has
				maintained drug-free screening results for three consecutive months, after
				which time random drug screening shall be performed at least monthly. A
				positive drug screening for drugs other than methadone during any phase of
				treatment shall require resumption of a sampling schedule as determined by the
				multi-disciplinary team. The opioid treatment program shall respond to
				continuing positive drug screening results for drugs other than methadone by
				documentation in the client's chart of more intensive treatment interventions,
				or referral to another treatment provider including residential
				treatment.
(c) Clients in clinic
				based medical maintenance, Phase VI, shall receive monthly drug screening and
				an additional two special call backs in the first year with subsequent call
				backs as delineated by program policy for determining client responsibility in
				handling extended take-homes and drug screening at the time of the special call
				backs.
(d) Prescription drug use
				identified by drug screening shall be considered a positive drug screening
				result if the client: has not provided documentation from the prescribing
				physician that the client is under care for a diagnosed medical condition;
				refuses to sign a release authorizing the opioid treatment program to contact
				the prescribing physician; or has not documented to the opioid treatment
				program that the physician is aware that the client is on methadone. Such
				documentation shall be reviewed and approved in writing by the medical director
				or opioid treatment program physician.
(e) Client acknowledgement of drug use shall
				void the necessity of drug testing, shall be considered a positive drug
				screening, and shall result in appropriate actions as described
				above.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.10 - Eligibility for take-home medication

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				multidisciplinary team shall utilize the criteria outlined in the Federal
				standards set by accrediting agencies at 42 CFR Part 8.12, in determining
				whether or not a client is eligible to receive take home medication and meets
				all the eligibility criteria.
1. Any client
				in an opioid treatment program receiving comprehensive maintenance treatment
				may receive a single take-home dose for a day that the clinic is closed for
				business, including Sundays and State and Federal holidays.
i. The facility shall make arrangements to
				provide the clinically appropriate take-home dose should the facility remain
				closed for business, on a non-emergency basis, for more than one day. This
				provision shall have been approved by the medical director, reviewed by the
				treatment team, and supported by documentation in the client record.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.11 - Labeling of take-home medication

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Take-home
				medication provided to eligible clients shall be provided in a child-proof
				container in accordance with the Poison Prevention Packaging Act ( PL 91-601,
15
				U.S.C. 1471,
Federal Consumer
				Product Safety Commission, http://www.cpsc.gov//Global/PDF/Statues/pppa.pdf and
				shall be labeled as follows:
Name, address, and telephone number of the opioid treatment
				  program
Date of issue
Client's full name
Name and strength of drug
Number of doses, if multiple dose
Directions for use
Name of prescribing Physician or advanced practice
				  nurse
Warning/caution statement
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.12 - Take-home medication dosage schedule

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An opioid
				treatment program shall develop and implement written policies and procedures
				consistent with this chapter and all applicable Federal regulations addressing
				the following issues:
1. A client meeting the
				standards set by accrediting agencies for consideration of take-home medication
				may be permitted take-home medication in accordance with the following schedule
				based upon the review and documented approval by the multidisciplinary team:
i. For six-day programs, on admission--one
				daily take-home dose;
ii. For all
				programs, after three consecutive months of negative drug screens--one to two
				daily take-home doses;
iii. After
				an additional three consecutive months, or a total of six consecutive months of
				negative drug screens--three daily take-home doses;
iv. After an additional three consecutive
				months or a total of nine consecutive months of negative drug screens--four
				daily take-home doses;
v. After an
				additional three consecutive months, or a total of 12 consecutive months of
				negative drug screens--five daily take-home doses; and
vi. After an additional six consecutive
				months or a total of 18 consecutive months of negative drug screens --six daily
				take-home doses.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.13 - Extended take-home medications

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Clients in
				opioid treatment programs who have 24 and 36 consecutive months of stability in
				treatment, and who have been determined and documented as eligible by the
				multidisciplinary team, may be approved for extended take-homes as follows:
1. A Phase V client who has had no positive
				drug screening results within the last twenty-four consecutive months may be
				permitted up to a 14-day supply of take-home medication, provided the client
				meets the criteria for stability and functioning contained in the standards set
				by accrediting agencies as determined and documented by the multidisciplinary
				team.
2. A Phase VI client who has
				no positive drug screening results within the last 36 consecutive months may be
				permitted up to a 30-day supply of take-home medication, provided the client
				meets the criteria for stability and functioning contained in the standards set
				by accrediting agencies as determined and documented by the multidisciplinary
				team.
3. Clients receiving up to 14
				or up to a 30-day supply of daily take-home doses who have a positive drug
				screen shall be assessed by the multidisciplinary team. This shall be
				documented and shall include a medication call back, drug screen and
				appropriate clinical interventions, which shall be documented in the client
				record. Any client who has been determined to have mishandled take-home
				medication shall no longer be eligible for take-homes until he or she has again
				met the initial criteria for take-homes, and been reviewed and approved by the
				multidisciplinary team.
4. Clients
				on extended take-homes who have had two positive drug screenings within a
				12-month period shall no longer be eligible for extended take-homes. Extended
				take-homes may be restored when the client has had 12 consecutive months of
				negative drug screening results and the multidisciplinary team has reviewed his
				or her progress in treatment and has recommended restoration of extended
				take-homes. Following restoration of extended take-homes, a positive drug
				screen shall result in the removal of extended take-homes until the client has
				had 12 consecutive months of negative drug screening results and been approved
				by the multidisciplinary team for reinstatement of extended take-homes. If the
				two positive drug screenings are within 90 days, all weekday take-homes shall
				be removed in accordance with
				10:161B-11.12.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.14 - Take-home exceptions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An opioid
				treatment program may request an exception of the take-home requirements
				contained in the standards set by accrediting agencies for a client deemed
				responsible in handling take-home medication who is unable to be medicated at
				the program due to illness, family emergency, job training, travel, etc. A
				request for exception is only necessary if the program physician makes a
				treatment decision that differs from the Federal regulatory requirements at 42
				CFR Part 8. A client's request for an exception of the take-home requirements
				contained in standards set by accrediting agencies shall be reviewed and
				approved by the multidisciplinary team, signed by a program physician and
				submitted by fax to the CSAT at 240-276-1630, or online per instructions at
				http://dpt.samhsa.gov/webintro.htm. A copy of the exemption request shall be
				concurrently submitted by fax to DMHAS, at 609-292-3816.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.16 - Office based opioid treatment

Current through Register Vol. 56, No. 14, July 15, 2024
An opioid treatment program seeking to affiliate with an
				  office based private physician for the provision of opioid treatment in the
				  physician's office shall request an exemption from the CSAT in accordance with
				  42 CFR Part 8. The opioid treatment program shall also file for a waiver in
				  accordance with
				  N.J.A.C.
				  10:161B-2.13, and shall be subject to
				  conditions imposed by DCN&L if the waiver is approved. Opioid treatment
				  programs utilizing Suboxone shall comply with all mandates from CSAT governing
				  the administration of Suboxone. All facilities shall comply with the DMHAS
				  Buprenorphine Guidelines, Administrative Bulletin 2007-03, incorporated herein
				  as chapter Appendix B.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.17 - Emergency phone coverage

Current through Register Vol. 56, No. 14, July 15, 2024
An opioid treatment program shall provide emergency
				  telephone coverage by a designated staff member or by other arrangements or
				  agreement 24 hours per day, seven days a week, to respond to clients in crisis,
				  verify client dose levels, etc.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 12 - DETOXIFICATION SERVICES › Section 10:161B-12.1 - Provision of outpatient detoxification services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				standards in this subchapter shall apply to all outpatient substance use
				disorder treatment programs approved by DCN&L to provide outpatient
				detoxification services, including opioid treatment programs providing
				short-term (that is, less than 30 days) opiate detoxification using methadone
				and/or other approved medications.
(b) The program shall accept and provide
				detoxification services only to clients meeting the ASAM Criteria, Level I-D or
				II-D.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 12 - DETOXIFICATION SERVICES › Section 10:161B-12.2 - Staff qualifications

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Programs
				providing outpatient detoxification services shall meet the following staffing
				requirements:
1. Outpatient detoxification
				services shall be under the direction of a medical director who meets the
				requirements set forth in
				10:161B-1.4, and who can
				demonstrate at least two years of direct experience in the provision of
				detoxification services.
2. If the
				program employs physicians under the direction of the medical director, such
				physicians shall not be required to be ASAM-certified but shall meet the
				experiential requirements of two years of direct experience providing
				detoxification services, and shall be supervised by the medical
				director.
3. If the program elects
				to employ advanced practice nurses (APNs) or physician assistants (PAs) to
				supplement the services of the medical director or other physicians, such
				practitioners shall operate in accordance with all applicable State statutes
				and rules. APNs and PAs shall be required to have at least two years of direct
				experience in the treatment of substance abusing and dependent individuals,
				including the provision of detoxification services.
4. A registered professional nurse shall be
				on duty at the program during all hours of operation when clients being detoxed
				are present. The registered professional nurse shall have specific training and
				experience in substance abuse treatment, including detoxification services. The
				registered professional nurse shall assess each client daily, seven days a
				week, including assessment of withdrawal symptoms using established written
				protocols, vital signs and drug screening in accordance with program policies.
				If the program administers medication onsite, the registered professional nurse
				shall reassess vital signs and withdrawal symptoms prior to the client's
				departure.
5. The program shall
				employ a director of substance abuse counseling who meets the qualifications
				set forth in
				10:161B-1.8.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 12 - DETOXIFICATION SERVICES › Section 10:161B-12.3 - Client eligibility for outpatient detoxification

Current through Register Vol. 56, No. 14, July 15, 2024
Clients admitted to outpatient detoxification shall meet the
				  admission criteria for either ASAM Level I-D (outpatient detoxification without
				  extended on-site monitoring) or Level II-D (outpatient detoxification with
				  extended on-site monitoring) of the ASAM Criteria. Priority admission for
				  detoxification services shall be given to pregnant women and individuals who
				  are HIV positive.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 12 - DETOXIFICATION SERVICES › Section 10:161B-12.5 - Policies and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Outpatient
				substance use disorder treatment programs approved by DCN&L to provide
				outpatient detoxification shall establish policies and procedures which are
				consistent with the ASAM Criteria, the CSAT Treatment Improvement Protocol (TIP
				19, 1995) publication "Detoxification From Alcohol and Other Drugs,"
				incorporated herein by reference (accessible to download from
http://www.taadas.org/publications/prodimages/TIP%2019.pdf
),
				and acceptable medical treatment practices within the disciplines providing
				client services for the following:
1. Medical
				assessment including physical examination;
2. Admission and exclusionary
				criteria;
3. Client
				consent/treatment agreement;
4.
				Drug specific detoxification protocols including, but not limited to, the
				following:
i. Withdrawal assessment
				instrument(s) used;
ii. Medications
				used to include purpose, frequency of administration and effectiveness;
				and
iii. Frequency of monitoring of
				vital signs to include pulse, respiration, blood pressure and
				temperature;
5. Alcohol
				and drug screening;
6.
				Staffing;
7. Hours of
				operation;
8.
				Emergencies;
9. Discharge criteria;
				and
10. Measuring treatment
				outcomes.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 13 - LABORATORY SERVICES › Section 10:161B-13.1 - Provision of laboratory services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The outpatient
				substance use disorder treatment program shall provide laboratory services
				directly in the program or shall ensure the availability of services through
				written affiliation agreements.
1. The
				program shall only contract with laboratories that are licensed or approved by
				the New Jersey Department of Health , in accordance with
N.J.A.C. 8:44
and 8:45, for the provision of drug screening and other diagnostic and
				screening tests if required by this chapter or otherwise provided by the
				program.
2. The facility shall
				establish and implement policies and procedures for obtaining, identifying,
				storing and transporting laboratory specimens.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 14 - PHARMACEUTICAL SERVICES › Section 10:161B-14.1 - Provision of pharmaceutical services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Any outpatient
				substance use disorder treatment program that administers or dispenses
				medication to clients shall either appoint a pharmacist as the director of
				pharmaceutical services, or engage a consultant pharmacist, to direct, provide,
				and monitor the quality of pharmaceutical services in accordance with this
				chapter, and who shall:
1. Work with the
				Pharmacy and Therapeutics Committee or Client Care Policy Committee, if
				established by the facility, in developing policies and procedures for the
				delivery of quality pharmaceutical services to clients of the program;
i. In instances where a client care policy
				committee is not established, such policies shall be consistent with the client
				care policies as required at N.J.A.C. 10:161B-6.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 14 - PHARMACEUTICAL SERVICES › Section 10:161B-14.3 - Standards for storage of medications

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The program
				shall keep all medications and intravenous solutions in locked storage areas,
				stored in accordance with manufacturer's instructions at or near the nursing
				unit(s).
1. The program shall store all
				medications that require refrigeration in a locked box within a refrigerator,
				in the locked medication room, at temperatures that conform to United States
				Pharmacopoeia requirements of 36 to 46 degrees Fahrenheit.
2. The program shall store all scheduled
				medications separate from non-scheduled medications unless unit dose.
3. The program shall keep all medications for
				external use separate from medications for internal use.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 15 - EMERGENCY SERVICES AND PROCEDURES › Section 10:161B-15.1 - Emergency plans and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The outpatient
				substance use disorder treatment facility shall maintain written emergency
				plans, policies, and procedures to be followed in case of hazards that
				necessitate an evacuation, ensuring that clients receive necessary services
				during the evacuation or other emergency, including internal and external
				disasters such as fire, natural disaster, environmental threats, bomb threats,
				or industrial or radiological accidents.
(b) Procedures for emergencies shall include:
1. Protocols for notification of emergency
				service providers, officials and DAS;
i. DHS
				emergency notification shall follow at least the non-emergency notification
				requirements of
10:161B-1.7(c)
14;
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 15 - EMERGENCY SERVICES AND PROCEDURES › Section 10:161B-15.2 - Drills, tests and inspections

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The facility
				shall conduct and document drills of emergency plans annually and as follows:
1. On an annual basis, fire emergency drills
				shall be conducted at least quarterly during each of two shifts (eight drills
				per annum);
2. On an annual basis,
				emergency disaster drills other than fire, that is, hurricane, natural
				disasters, bomb threat, loss of water, loss of power, radiological, biological
				or chemical incidents, shall be conducted at least quarterly (four drills per
				annum); and
3. The facility shall
				maintain documentation of all drills, including the date, hour, description of
				the drill, participating staff, and signature of the person in charge of the
				drill.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 15 - EMERGENCY SERVICES AND PROCEDURES › Section 10:161B-15.3 - Emergency medical services

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The facility
				shall establish written policies and procedures that are reviewed annually and
				revised as needed, for the provision of emergency services based on the types
				of clients typically treated at the program, including policies and procedures
				regarding emergency kits and emergency carts, if applicable.
1. The facility shall be able to respond to
				medical emergencies occurring on-site during its hours of operation.
2. The facility shall make provision for
				emergency transportation to, and emergency medical services at, a nearby
				hospital.
3. The facility shall
				specify the locations, contents, frequency of review, expiration date, and
				staff assigned to review emergency kits and emergency carts, as applicable, and
				shall ensure that emergency kits are kept secure, but not under lock and
				key.
4. The facility shall require
				that at least one person, trained in the use of the emergency equipment
				maintained on-site, is available whenever there is a client on-site.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 16 - CLIENT RIGHTS › Section 10:161B-16.1 - Establishment of policies and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				outpatient substance use disorder treatment program shall establish, implement
				and conspicuously post written policies and procedures regarding the rights of
				clients, including appeals procedures for involuntary discharge, which shall be
				available to clients, staff, and the public.
(b) The program shall provide annual
				in-service education to its staff concerning the implementation of policies and
				procedures regarding client rights, and as part of new employee
				orientation.
(c) The program shall
				comply with all applicable Federal and State statutes and rules concerning
				client rights.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 16 - CLIENT RIGHTS › Section 10:161B-16.3 - Complaints

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The administrator shall provide all
				clients and their families, upon request, the name, address, and telephone
				number of the following State office where clients and their families may
				submit complaints:
New Jersey State Department of Human Services
Division of Mental Health and Addiction Services
PO Box 700
Trenton, New Jersey 08625-0700
Telephone: toll-free 1-877-712-1868
(b) The administrator shall provide all
				clients and their families, upon request, the names, address, and telephone
				numbers of offices where information concerning Medicaid coverage may be
				obtained.
(c) The program shall
				develop a policy and procedure in which clients are able to voice grievances or
				recommend changes of policies and services to agency personnel and the
				governing authority without fear of reprisal.
(d) The administrator shall also
				conspicuously post the DHS address and telephone number in (a) above, and
				Medicaid coverage contact information, in the admissions waiting area or room,
				in the client service area of the business office, and in other public areas
				throughout the facility.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 17 - DISCHARGE PLANNING SERVICES › Section 10:161B-17.1 - Discharge/continuum of care planning

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The outpatient
				substance use disorder treatment program shall initiate discharge/continuum of
				care planning for each client upon admission.
1. Goals for discharge shall be incorporated
				in the client's treatment plan at admission and shall address problems
				identified at admission and during treatment.
i. Such goals shall be shared with the
				substance abuse counselor staff and supervisor, and routinely reviewed and
				assessed with the client and the client's treatment team.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 17 - DISCHARGE PLANNING SERVICES › Section 10:161B-17.2 - Discharge/continuum of care planning policies and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The program
				shall establish and implement written policies and procedures for
				discharge/continuum of care planning services, which shall address at least the
				following:
1. The staff responsible for
				planning, providing, and/or coordinating discharge/continuum of care planning
				services, including:
i. Making referrals to
				community agencies (for example, mental health agencies) and resources for
				clinically appropriate services in the continuum of care; and
ii. Promoting and facilitating the continuing
				involvement of clients with support groups, such as Alcoholics Anonymous (AA)
				and Narcotics Anonymous (NA), following discharge;
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 17 - DISCHARGE PLANNING SERVICES › Section 10:161B-17.3 - Client and family education

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The program
				shall include education of the client and his or her family, if applicable, or
				legally authorized representative as part of its discharge/continuum of care
				planning service and shall provide information regarding the following:
1. Community agencies and resources available
				for support services, health care facilities, including but not limited to, the
				identification of resources for prenatal care, services for the treatment of
				HIV infection, vocational rehabilitation centers, Women, Infants and Children
				(WIC) Program, and legal and social service agencies; and
2. The availability of support groups and
				referrals, when appropriate, to programs including but not limited to Narcotics
				Anonymous (NA), Nar-Anon, Alcoholics Anonymous (AA), Al-Anon, and
				Alateen.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 18 - CLINICAL RECORDS › Section 10:161B-18.1 - Maintenance of clinical records

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The outpatient
				substance use disorder treatment program shall establish and implement policies
				and procedures for production, maintenance, retention, and destruction of
				clinical records, which shall be reviewed at least annually by the
				administrator. The policy and procedure manual shall address the written
				objectives, organizational plan, and quality assurance program for all clinical
				records, subject to the following:
1. The
				facility shall establish a clinical record for each client;
2. The facility shall require that
				documentation of all services provided and transactions regarding the client
				are entered in his or her clinical record in a uniform manner;
3. The facility shall maintain all clinical
				records and components thereof on-site at all times unless:
i. The clinical record is removed in
				accordance with a court order;
ii.
				The clinical record is removed due to a physical plant emergency or natural
				disaster; or
iii. Off-site storage
				of clinical records is approved by DCN&L pursuant to
				N.J.A.C.
				10:161B-18.6; and
4. The facility shall preserve the
				confidentiality of information contained in the clinical record in accordance
				with Federal statutes and rules for the Confidentiality of Alcohol and Drug
				Abuse Client Records at
				42 U.S.C. §§
											290dd-2 and
				290ee-2
				and 42 CFR Part 2,
				§§
											2.1 et seq. and the provisions
				of the Health Insurance Portability and Accountability Act (HIPAA) at 45 CFR
				Parts 160 and 164.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 18 - CLINICAL RECORDS › Section 10:161B-18.2 - Assignment of responsibility

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				administrator and director of substance abuse counseling services shall ensure
				that clinical records are maintained.
(b) The facility shall designate a staff
				member to act as the coordinator of clinical record services and one or more
				staff to act in his or her absence to ensure staff access to clinical records
				at all times, if such an individual is needed to comply with (a)
				above.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 18 - CLINICAL RECORDS › Section 10:161B-18.4 - Requirements for clinical record entries

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The facility
				shall require that all orders for client care be prescribed in writing, signed
				and dated by the prescriber(s), in accordance with State law.
1. All medical orders, including verbal
				orders, shall be verified or countersigned in writing within 72 hours and in
				accordance with State law.
New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 18 - CLINICAL RECORDS › Section 10:161B-18.5 - Access to clinical records

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The facility
				shall furnish a legible, written copy of the clinical record, or portion of the
				clinical record, as appropriate, for a fee based on actual costs to a client,
				his or her legally authorized representative, or a third party payer, upon
				written request and receipt of a properly executed release of information form
				within 30 days of receipt of the written request, in accordance with the
				following:
1. The fee for copying shall not
				exceed $ 1.00 per page for the first 100 pages, and $.25 per page thereafter,
				not to exceed $ 200.00 for the entire record.
2. In addition to per page costs, the
				following charges are permitted:
i. A search
				fee of no more than $ 10.00 per request; and
ii. A postage charge of actual costs for
				mailing, not to exceed $ 5.00.
3. No charges shall be assessed other than
				those permitted in (a)1 and 2 above.